A comparative pharmacokinetic study of valpromide and valproic acid after intravenous administration in humans

Meir Bialer*, Abraham Rubinstein, Joseph Dubrovsky, Itamar Raz, Oded Abramsky

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

The pharmacokinetics of valpromide and valproic acid were investigated comparatively in 6 healthy subjects after intravenous administration of the two drugs. Valpromide was very rapidly and almost completely biotransformed to valproic acid (fm = 81.2 ± 10.5%; mean ± S.D.; n = 6). Relative to valproic acid valpromide has a very short half-life (0.84 ± 0.33 h) a high-clearance value (70 ± 30.5 l/h) and a large volume of distribution (Vβ = 75.3 ± 12.7 l). The results of this study showed that there was no significant difference between the biotransformation of valpromide to valproic acid after intravenous administration and that obtained after oral administration of valpromide. Therefore, in humans, valpromide appears to be a prodrug of valproic acid after intravenous as well as oral administration.

Original languageEnglish
Pages (from-to)25-33
Number of pages9
JournalInternational Journal of Pharmaceutics
Volume23
Issue number1
DOIs
StatePublished - Jan 1985

Fingerprint

Dive into the research topics of 'A comparative pharmacokinetic study of valpromide and valproic acid after intravenous administration in humans'. Together they form a unique fingerprint.

Cite this